Ascentage Pharma Group International (HKG:6855)

HKG:6855 Revenue

Ascentage Pharma Group International had revenue of 302.21M CNY in the half year ending June 30, 2026, a decrease of -63.31%. This brings the company's revenue in the last twelve months to 642.64M, up 64.52% year-over-year. In the year 2025, Ascentage Pharma Group International had annual revenue of 574.12M, down -41.46%.

• Revenue (ttm): 642.64M CNY
• Revenue Growth: +64.52%
• P/S Ratio: 16.66
• Revenue / Employee: 837.86K CNY
• Employees: 767
• Market Cap: 12.36B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	574.12M	-406.53M	-41.46%
Dec 31, 2024	980.65M	758.67M	341.77%
Dec 31, 2023	221.98M	12.27M	5.85%
Dec 31, 2022	209.71M	181.80M	651.38%
Dec 31, 2021	27.91M	15.46M	124.18%
Dec 31, 2020	12.45M	-2.06M	-14.21%
Dec 31, 2019	14.51M	7.71M	113.21%
Dec 31, 2018	6.81M	479.00K	7.57%
Dec 31, 2017	6.33M	-1.34M	-17.46%
Dec 31, 2016	7.67M	-	-

Data Source: Fiscal.ai Last updated: Dec 31, 2025

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 20, 2026

Data Sources Report a data error